Skip to main content
. Author manuscript; available in PMC: 2010 Sep 3.
Published in final edited form as: Differentiation. 2002 Dec;70(9-10):537–546. doi: 10.1046/j.1432-0436.2002.700907.x

Fig. 3.

Fig. 3

Reversion of HMT-3522 T4–2 cells. A Reversion by inhibition of EGFR using function-blocking antibodies. Green, actin; red, nuclei. B Phenotypic reversion by inhibition of β1 integrins occurs against a constant genetic background (A reproduced from Wang et al., 1998; B reproduced with modifications by permission of Journal of Cell Biology from Weaver et al., 1997; CGH data, Joe Gray and Bissell laboratories, manuscript in preparation).